Articles Published in 2013

PPD names David Johnston executive vice president

Tuesday, August 13, 2013 11:30 AM

CRO Pharmaceutical Product Development (PPD) has appointed David Johnston, Ph.D., executive vice president of global laboratory services. Johnston directs PPD’s comprehensive laboratory services, including bioanalytical, vaccines and biologics, current good manufacturing practice (cGMP) and central laboratories.

More... »

Cronos Clinical Consulting Services relocates

Tuesday, August 13, 2013 11:00 AM

Cronos Clinical Consulting Services, a global neuroscience-focused clinical data quality control organization, has relocated headquarters to Lambertville, N.J.

More... »

Torrey Pines Investment, BioMotiv partner for drug development investments

Tuesday, August 13, 2013 10:30 AM

San Diego, Calif.-based Torrey Pines Investment (TPI), a specialty life-science investor, and BioMotiv, an accelerator company associated with The Harrington Project for Discovery & Development, have signed a joint investment framework to fund early stage life-science programs and companies over the next seven years. 

More... »

PTC Therapeutics announces milestone in SMA collaboration

Tuesday, August 13, 2013 10:00 AM

PTC Therapeutics has announced the selection of a development candidate in its spinal muscular atrophy (SMA) collaboration with Roche and the SMA Foundation. The achievement of the milestone triggers a $10 million payment to PTC from Roche.

More... »

Sciformix expands offices to the Philippines

Tuesday, August 13, 2013 09:30 AM

Sciformix, a Scientific Process Organization (SPO), has opened offices in Manila, the Philippines. Sciformix intends to add more than 200 employees in the Philippines, said Manish Vinayak Soman, Sciformix president and chief executive officer.

More... »

Telormedix receives E.U. funding for Psoriasis treatment

Tuesday, August 13, 2013 09:00 AM

Telormedix, a clinical stage biopharmaceutical company focused on toll-like receptor 7 (TLR7) small molecules in the treatment of cancer and inflammatory diseases, has raised funding from the European Eurostars Program to coordinate an international research project involving a consortium of companies aimed at developing new formulations of one of the company’s drug candidates, TMX-302, for the treatment of psoriasis.

More... »

Quest Diagnostics launches opioid therapy genetic test

Monday, August 12, 2013 04:23 PM

Quest Diagnostics, a provider of diagnostic information services, has launched a lab-developed genetic test to aid the delivery of personalized opioid pain-relieving treatment. It is the first clinical lab to offer testing for variants in all cytochrome P450 (CYP450) genes known to influence the CYP450 enzyme system, which affects metabolism of opioids and other medications.

More... »

Anne Lindblad promoted to president and CEO of EMMES

Monday, August 12, 2013 04:18 PM

EMMES has promoted executive vice president Dr. Anne Lindblad to president and chief executive officer. Lindblad replaces Dr. Donald (Don) Stablein, who has been named past president. Stablein, who joined the company in 1980, has been president/CEO since 1992. In his new role as past president, he will continue to provide project support and will be an ambassador for EMMES.

More... »

Roche launches GS FLX+ System software update

Monday, August 12, 2013 03:37 PM

Roche has launched a software update that extends the range of amplicon lengths available for targeted next-generation sequencing studies on the 454 GS FLX+ System. The latest software enables sequencing of amplicons up to 800bp while maintaining >99% accuracy over the length of the read.

More... »

CollabRx launches clinical cancer sequencing commercial service

Monday, August 12, 2013 01:17 PM

CollabRx, a data analytics company focused on informing clinical decision making in molecular medicine, has launched the Genetic Variant Annotation (GVA) service. The service is a new product and the company's first offering for the clinical laboratory market. CollabRx will provide GVA to the molecular diagnostic segment of the clinical laboratory market, which includes reference laboratories, hospital laboratories, research institutions and laboratories within academic medical centers.

More... »